Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC
Clinical trial NCT00960297 · TERMINATED
Trial details
- NCT number
- NCT00960297
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.